MELISSA ODLE: Open Payments
NPI 1225308406 · SESSER, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 42 payments from 12 companies in 2025. Trend: 2023 $436 · 2024 $447 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $186 |
| Ipsen Biopharmaceuticals, Inc | 5 | $90 |
| Ardelyx, Inc. | 4 | $76 |
| Novo Nordisk Inc | 4 | $67 |
| Madrigal Pharmaceuticals | 2 | $52 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Viatris Specialty LLC | 2 | $36 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
Products named: IQIRVO, LINZESS, IBSRELA, REZDIFFRA, NUZYRA, SKYRIZI, ENTYVIO, YUPELRI.
Industry payments across IL — which companies pay providers there.
